US President Joe Biden yesterday expressed support for a Israel-Gaza ceasefire in a call with Israel’s Prime Minister Netanyahu, and today EU foreign ministers will meet to discuss the conflict, and a biotech company developing medicines that mimic the painkilling effects of cannabis is set to list in London this week. Plus, the FT’s South China correspondent, Primrose Riordan, explains why activists are calling BlackRock “inconsistent” in its ESG commitments.
Biden backs ceasefire in Israel-Palestinian conflict
https://www.ft.com/content/d388d8b4-94ce-49d1-b8ab-df171286fdad
Europeans hamstrung by rifts on Gaza conflict
https://www.ft.com/content/6c42bcb1-7013-4b74-8526-35ef7fae6f5d?
Start-up focused on painkilling effects of cannabis to list in London
https://www.ft.com/content/2952b9c9-f14a-4300-b1ac-d6c6bf5f8c8f?
BlackRock accused of ESG inconsistency over Indonesia palm oil
https://www.ft.com/content/479b9dd2-c738-4310-8b1e-afdfbd3921b0
Hosted on Acast. See acast.com/privacy for more information.
Podcasten FT News Briefing är inbäddad på denna sida från ett öppet RSS-flöde. Alla filer, beskrivningar, bilder och annan metadata från flödet tillhör podcastens ägare och är inte anslutet till eller validerat av Podplay.